News & Events – IP Group plc

Search in site

IP Group news

07 Jan 2026

Portfolio company Pulmocide announces termination of Opera-T Phase 3 study with Opelconazole

IP Group plc

17 Nov 2025

Portfolio company Artios completes oversubscribed $115m Series D financing round

IP Group plc

13 Oct 2025

Update on potential future royalty income from Metsera obesity drug candidates

IP Group plc

See all IP Group news

Portfolio news

08 Jan 2026

Moa Technology and Certis Belchim announce strategic collaboration for new Moa Amplifier™

MoA Technology Ltd

08 Jan 2026

STORM Therapeutics and AlidaBio Announce Strategic Collaboration to Accelerate Development of Cancer Therapies Targeting RNA Modifications

Storm Therapeutics

07 Jan 2026

Pulmocide announces termination of Opera-T Phase 3 study with Opelconazole

Pulmocide Ltd

See all portfolio news

Events

September 2025

17

2025 Half Year Results Webinar

Virtual

Event has passed

June 2025

26

Capital Markets Day

45 Gresham Street, London

Event has passed

June 2025

12

AGM

Hybrid

Event has passed

Downloads and key links